- Home
- REBN vs XXII Comparison
REBN vs XXII Comparison
Compare REBN & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REBN | XXII |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7M | 6.9M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | REBN | XXII |
|---|---|---|
| Price | $1.80 | $0.80 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 134.0K | ★ 155.4K |
| Earning Date | 11-19-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $6,663,303.00 | ★ $20,346,000.00 |
| Revenue This Year | $335.98 | N/A |
| Revenue Next Year | N/A | $79.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 21.09 | 16.98 |
| 52 Week Low | $1.36 | $0.75 |
| 52 Week High | $8.30 | $140.92 |
Technical Indicators
Market Signals| Indicator | REBN | XXII |
|---|---|---|
| Relative Strength Index (RSI) | 55.86 | 40.68 |
| Support Level | $1.50 | $0.81 |
| Resistance Level | $1.97 | $0.89 |
| Average True Range (ATR) | 0.16 | 0.07 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 66.06 | 26.17 |
Price Performance
Historical ComparisonAbout REBN Reborn Coffee Inc.
Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.